Market Overview

A Promising Outlook on the US Cancer Vaccine Market 2018: Opportunities in Therapeutic & Adjuvant Cancer Vaccines -


The "Promising
Outlook - US Cancer Vaccine Market"
report has been added to's

According to the report, the US is the largest market for cancer
vaccines amongst all the geographic regions worldwide.

On the basis of type of cancer for which the vaccine is targeted, the
market has been segmented into three types, namely liver cancer, HPV
related cancer, and others. On the basis of type of vaccine, the market
has been further sub-divided into prophylactic vaccines and therapeutic

The prophylactic vaccines accounted for the largest share in 2017. The
large share of this market is attributed to various vaccination programs
organized by the US government for prevention against HPV and hepatitis.
The therapeutic vaccines are expected to witness high growth in coming
years due to strong pipeline.

Furthermore, the report also covers the FDA's vaccine approval
procedure, and its guidance to the industry for developing therapeutic
cancer vaccines. Additionally, the report also enlists the pipeline of
cancer vaccines which are in various clinical trial phases. The patent
analysis of products in US has also been added in the report on the
basis of year of grant, type of patent, and assignee of the patent.

The prominent players in US Cancer Vaccines Market have been discussed
in the last section of the report. A brief business overview and
financial information about each of these players has been provided,
along with their product portfolios, product pipeline and recent
developments. Overall, the research contains exhaustive information that
will help clients in formulating market strategies and assessing
opportunity areas in the US Cancer Vaccines Market.

Market Dynamics


  • Rising Cancer Incidences
  • Ability to Reduce Healthcare Expenditure
  • Rising Awareness
  • Patient Assistance Programs
  • Government Initiatives
  • Strong Pipeline
  • Technological Advancements


  • High Cost of Cancer Vaccines
  • Side-Effects of Cancer Vaccines
  • Vaccine Supply Shortages
  • Insurance Issues Related to Cancer Vaccination


  • Therapeutic Cancer Vaccines
  • Adjuvant Cancer Vaccines

Key Topics Covered

1. Analyst View

2. Research Methodology

3. Cancer Statistics by Demographics

4. Market Dynamics

5. Cancer Vaccines Market Outlook

6. Cancer Vaccines Market by Cancer Type

7. Cancer Vaccine Market by Application

8. Potential Cancer Vaccine Candidates: An Opportunity Assessment

9. US Patent Analysis

10. Regulatory Environment

11. Competitive Landscape

12. Company Profiles

  • Amgen Inc.
  • Dendreon Pharmaceuticals LLC
  • GlaxoSmithKline PLC
  • Merck & Co. Inc.

For more information about this report visit

View Comments and Join the Discussion!